IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of “Moderate Buy” by Analysts
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the sixteen analysts that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the […]
More Stories
AT&T (NYSE:T) Stock Price Expected to Rise, UBS Group Analyst Says
AT&T (NYSE:T – Get Free Report) had its price objective boosted by research analysts at UBS Group from $25.00 to...
Susan C. Schnabel Acquires 2,500 Shares of Kayne Anderson BDC, Inc. (NYSE:KBDC) Stock
Kayne Anderson BDC, Inc. (NYSE:KBDC – Get Free Report) Director Susan C. Schnabel purchased 2,500 shares of the business’s stock...
Emily Halverson Sells 1,329 Shares of Alaska Air Group, Inc. (NYSE:ALK) Stock
Alaska Air Group, Inc. (NYSE:ALK – Get Free Report) VP Emily Halverson sold 1,329 shares of Alaska Air Group stock...
Dayforce (NYSE:DAY) Price Target Raised to $90.00
Dayforce (NYSE:DAY – Free Report) had its price objective upped by Stifel Nicolaus from $82.00 to $90.00 in a report...
Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com
StockNews.com upgraded shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a sell rating to a hold rating in a...
Choice Properties Real Est Invstmnt Trst (TSE:CHP.UN) Given a C$15.50 Price Target at National Bankshares
National Bankshares set a C$15.50 price objective on Choice Properties Real Est Invstmnt Trst (TSE:CHP.UN – Free Report) in a...